• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Landscape Analysis of the Application of Artificial Intelligence and Machine Learning in Regulatory Submissions for Drug Development From 2016 to 2021.

作者信息

Liu Qi, Huang Ruihao, Hsieh Julie, Zhu Hao, Tiwari Mo, Liu Guansheng, Jean Daphney, ElZarrad M Khair, Fakhouri Tala, Berman Steven, Dunn Billy, Diamond Matthew C, Huang Shiew-Mei

机构信息

Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

Office of Medical Policy, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

出版信息

Clin Pharmacol Ther. 2023 Apr;113(4):771-774. doi: 10.1002/cpt.2668. Epub 2022 Jun 16.

DOI:10.1002/cpt.2668
PMID:35707940
Abstract
摘要

相似文献

1
Landscape Analysis of the Application of Artificial Intelligence and Machine Learning in Regulatory Submissions for Drug Development From 2016 to 2021.2016年至2021年人工智能和机器学习在药物研发监管申报中的应用情况分析
Clin Pharmacol Ther. 2023 Apr;113(4):771-774. doi: 10.1002/cpt.2668. Epub 2022 Jun 16.
2
Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.人工智能驱动的抗神经退行性治疗药物识别与开发的最新趋势。
Mol Divers. 2021 Aug;25(3):1517-1539. doi: 10.1007/s11030-021-10274-8. Epub 2021 Jul 19.
3
Artificial Intelligence in Pharmaceutical Field - A Critical Review.人工智能在制药领域的应用——批判性综述。
Curr Drug Deliv. 2021;18(10):1456-1466. doi: 10.2174/1567201818666210617100613.
4
Machine Learning in Drug Discovery and Development Part 1: A Primer.机器学习在药物发现和开发中的应用（一）：概论。
CPT Pharmacometrics Syst Pharmacol. 2020 Mar;9(3):129-142. doi: 10.1002/psp4.12491. Epub 2020 Mar 11.
5
Artificial intelligence-driven prediction of multiple drug interactions.人工智能驱动的多种药物相互作用预测。
Brief Bioinform. 2022 Nov 19;23(6). doi: 10.1093/bib/bbac427.
6
Artificial intelligence in spine care: current applications and future utility.人工智能在脊柱护理中的应用：当前的应用和未来的效用。
Eur Spine J. 2022 Aug;31(8):2057-2081. doi: 10.1007/s00586-022-07176-0. Epub 2022 Mar 27.
7
Machine Learning and Deep Learning in Medical Imaging: Intelligent Imaging.医学成像中的机器学习与深度学习：智能成像
J Med Imaging Radiat Sci. 2019 Dec;50(4):477-487. doi: 10.1016/j.jmir.2019.09.005. Epub 2019 Oct 7.
8
Artificial Intelligence and Applications in PM&R.人工智能与 PM&R 中的应用。
Am J Phys Med Rehabil. 2019 Nov;98(11):e128-e129. doi: 10.1097/PHM.0000000000001171.
9
Clinical Trials and Machine Learning: Regulatory Approach Review.临床试验与机器学习：监管方法综述
Rev Recent Clin Trials. 2021;16(4):341-350. doi: 10.2174/1574887116666210715114203.
10
Artificial Intelligence and Machine Learning in Anesthesiology.人工智能和机器学习在麻醉学中的应用。
Anesthesiology. 2019 Dec;131(6):1346-1359. doi: 10.1097/ALN.0000000000002694.

引用本文的文献

1
AI-NLME: A New Artificial Intelligence-Driven Nonlinear Mixed Effect Modeling Approach for Analyzing Longitudinal Data in Randomized Placebo-Controlled Clinical Trials.AI-NLME：一种用于分析随机安慰剂对照临床试验中纵向数据的新型人工智能驱动的非线性混合效应建模方法。
Clin Transl Sci. 2025 Sep;18(9):e70345. doi: 10.1111/cts.70345.
2
Applied intelligence in clinical drug development: Potential benefits and emerging concerns.临床药物开发中的应用智能：潜在益处与新出现的问题。
Perspect Clin Res. 2025 Jul-Sep;16(3):127-131. doi: 10.4103/picr.picr_37_25. Epub 2025 May 27.
3
Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments.
制药GMP环境中人工智能/机器学习实施的监管视角
Pharmaceuticals (Basel). 2025 Jun 16;18(6):901. doi: 10.3390/ph18060901.
4
Strengthening the Use of International Collaborative Regulatory Assessments and Regulatory Alignment- Implications for Global Convergence.加强国际合作监管评估及监管协调的应用——对全球趋同的影响
Ther Innov Regul Sci. 2025 Jun 8. doi: 10.1007/s43441-025-00817-8.
5
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review.评估基于人工智能的模型驱动药物研发（MIDD）的影响：一项比较性综述。
AAPS J. 2025 Jun 2;27(4):102. doi: 10.1208/s12248-025-01075-0.
6
AI-Driven Applications in Clinical Pharmacology and Translational Science: Insights From the ASCPT 2024 AI Preconference.临床药理学与转化科学中的人工智能驱动应用：来自2024年美国临床药理学与治疗学协会人工智能会前研讨会的见解
Clin Transl Sci. 2025 Apr;18(4):e70203. doi: 10.1111/cts.70203.
7
The applications and advances of artificial intelligence in drug regulation: A global perspective.人工智能在药品监管中的应用与进展：全球视角
Acta Pharm Sin B. 2025 Jan;15(1):1-14. doi: 10.1016/j.apsb.2024.11.006. Epub 2024 Nov 13.
8
Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective.从监管角度看人工智能/机器学习在药物和生物制品研发中的应用
Pharmaceuticals (Basel). 2025 Jan 3;18(1):47. doi: 10.3390/ph18010047.
9
First, Do No Harm: Addressing AI's Challenges With Out-of-Distribution Data in Medicine.首先，勿伤为先：利用医学领域分布外数据应对人工智能的挑战。
Clin Transl Sci. 2025 Jan;18(1):e70132. doi: 10.1111/cts.70132.
10
Comparison of Different Machine Learning Methodologies for Predicting the Non-Specific Treatment Response in Placebo Controlled Major Depressive Disorder Clinical Trials.在安慰剂对照的重度抑郁症临床试验中预测非特异性治疗反应的不同机器学习方法比较
Clin Transl Sci. 2025 Jan;18(1):e70128. doi: 10.1111/cts.70128.